The Oncology Institute, Inc. (NASDAQ:STLN) — Market Cap & Net Worth
Market Cap & Net Worth: The Oncology Institute, Inc. (STLN)
The Oncology Institute, Inc. (NASDAQ:STLN) has a market capitalization of $640.89 Million ($640.89 Million) as of October 10, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #11039 globally and #2852 in its home market, demonstrating a 6.68% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying The Oncology Institute, Inc.'s stock price $6.63 by its total outstanding shares 99982933 (99.98 Million).
The Oncology Institute, Inc. Market Cap History: 2026 to 2026
The Oncology Institute, Inc.'s market capitalization history from 2026 to 2026. Data shows growth from $662.89 Million to $662.89 Million (0.00% CAGR). Check STLN stock price and chart for real-time trading data and today's change.
The Oncology Institute, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how The Oncology Institute, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see The Oncology Institute, Inc. cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of STLN by Market Capitalization
Companies near The Oncology Institute, Inc. in the global market cap rankings as of October 10, 2026. See how leveraged is The Oncology Institute, Inc.'s balance sheet to understand what proportion of total assets are financed by equity.
Key companies related to The Oncology Institute, Inc. by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #290 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #958 globally with a market cap of $27.89 Billion USD ( €23.86 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #991 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1224 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #290 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $451.09 |
| #958 | Fresenius SE & Co. KGaA | XETRA:FRE | $27.89 Billion | €42.36 |
| #991 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1224 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $263.78 |
The Oncology Institute, Inc. Historical Marketcap From 2026 to 2026
Between 2026 and today, The Oncology Institute, Inc.'s market cap moved from $662.89 Million to $ 662.89 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $662.89 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 10th, 2026 the market cap of The Oncology Institute, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $640.89 Million USD |
| MoneyControl | $640.89 Million USD |
| MarketWatch | $640.89 Million USD |
| marketcap.company | $640.89 Million USD |
| Reuters | $640.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About The Oncology Institute, Inc.
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educatio… Read more